Search

Conclusion: The use of L. kerstingii and F. thonningii for the treatment of helminthiasis has been proved in vitro and in silico by this research. However, more research is required, especially on the acute toxicity and in vivo anthelmintic efficacy to validate this scientific investigation.

Previous studies have reported interactions between Salmonella spp. and some helminth coinfections. In this study, S. typhimurium and Ascaridia galli coinfections were analyzed, and the consequences on therapy were proposed. In a first experiment where the effect of the bacteria on the nematode was evaluated, thirty 42-day-old broiler chickens were divided into 3 groups and coinfected with both parasites. The rate of A. galli egg inoculum was kept constant at 500/ml while that of S. typhimurium varied as follows: T0 (500 A. galli eggs/ml), T104 (500 A. galli eggs/ml+104 S. typhimurium CFUs), and T106 (500 A. galli eggs/ml +106S. typhymurium CFUs). EPG and parasitic load were measured using the McMaster technic, and number of worms and their length were also measured. We observed that T106 containing 106 CFUs of Salmonella significantly reduced the EPG values, and this group recorded the lowest worm load ranging from 18 to 21 worms. Likewise, the length of the worms obtained with T104 and T106 appeared to be shorter than those of the control (T0). In a second experiment to assess the effects of the nematode on the bacteria, thirty 42-day-old broiler chickens were divided into 3 groups and coinfected with both parasites. The rate of S. typhimurium inoculum was kept constant at 106 CFUs while that of A. galli varied as follows: T0 (106CFUs), T500 (500 A. galli eggs/ml +106S. typhymurium CFUs), and T750 (750 A. galli eggs/ml +106S. typhymurium CFUs). Bacterial load was measured using Voogt technique. We observed that T500 increased the colonization time and prolonged the duration of S. typhimurium secretion. Salmonella appears to be a hyperparasite considering the deleterious effect on A. galli. Due to this, it may be prudent to combine anti-Salmonella treatment with anthelmintic so as to effectively treat pathologies caused by these two pathogens.

Background. One of the most dangerous Plasmodium species is Plasmodium falciparum. Hence, it causes a higher rate of mortality. The resistance of Plasmodium falciparum to the ACT (Artemisinin-based Combination Therapies) has led to the search for new antimalarial drugs. The purpose of this research was to assess the in vivo antiplasmodial activity of Entandrophragma cylindricum ethyl acetate extract to provide a scientific basis for the use of this medicinal plant to treat malaria. Methods. Entandrophragma cylindricum stem bark powder was macerated in ethyl acetate to obtain the extract. The extract liquid filtrate was concentrated, evaporated and dry using a Rotavapor. The Peter and Rane test were used for the suppressive and curative antiplasmodial activities at different doses (125, 250 and 500 mg/kg). A positive and negative control groups were administered chloroquine (5 mg/kg) and 10% hypromelose, respectively. To assess the parasitemia of the mice a thin blood smear was made. Results. The ethyl acetate extract completely (100%) inhibited the development of P. berghei in the suppressive test at the dose of 500 mg/kg while that of the curative test was inhibited at 95%. The extract-treated group (500 mg/kg) and (Chloroquine (5 mg/kg) group all survived. The negative control group recorded a 100% mortality rate. Conclusion. The present study provides scientific confirmation on the use of E. cylindricum stem bark as an antiplasmodial remedy. However, the identification of the mode of action and the purification of the active compounds are necessary for further studies.

Background. Malaria is one of the most critical diseases causing about 219 million cases worldwide in developing countries. The spread and development of resistance against chemical antimalarial drugs is one of the major problems associated with malaria control. The present study was to investigate the antimalarial efficacy of ethyl acetate extract and one fraction of Bidens pilosa in vivo in order to support the usage of this plant by traditional healers to treat malaria. Methods. The extracts were prepared by maceration of B. pilosa leaf powder in ethyl acetate. The liquid filtrate of the extract and the best in vitro antiplasmodial fraction using HPLC were concentrated and evaporated using a rotavapor under vacuum to dryness. The antimalarial activity of B. pilosa plant products were evaluated in vivo against Plasmodium berghei infected mice according to the Peter and Rane test. The antimalarial efficacy of the a selected crude extract (ethyl acetate extract) was evaluated at 125, 250, and 500 mg/kg, while a selected fraction from ethyl acetate extract (fraction 12) was evaluated at 62.5 and 125 mg/kg. Blood from experimental animals was collected to assess hematological parameters. Results. The crude extract of ethyl acetate and fraction 12 demonstrated 100% in vivo parasite suppressive activity at doses of 500 mg/kg and 125 mg/kg, respectively, for the crude extract and fraction 12. The mice treated with 250 and 500 mg/kg had their parasitemia (intraerythrocytic phase of P. Berghei) drop considerably, disappearing by the 8th day in mice receiving 500 mg/kg. The ethyl acetate extract of B. pilosa, fraction 12 showed an even higher antiplasmodial activity. By the 5th day of the experiment, the treatment led to a modification of hematological parameters in mice. The chloroquine (5 mg/kg), fraction 12 (125 mg/kg), and the crude extract (500 mg/kg) groups all survived the 30 days of the experiment, while the negative control group registered 100% of the deaths. Conclusion. This study scientifically supports the use of Bidens pilosa leaves in the traditional treatment of malaria. However, the mode of action and in vivo toxicity of the plant still need to be assessed.

A comparative in vitro study was carried out to determine the ovicidal and larvicidal activity of aqueous and ethanolic extracts of Ageratum conyzoides (Asteraceae) leaves on the eggs (unembryonated and embryonated), first and second larval stages of Heligmosomoides bakeri. Four different concentrations (0.625, 1.25, 2.5, and 3.75 mg·mL−1) of both aqueous and ethanolic extracts were tested. Distilled water and 5% tween were used as negative controls in the bioassay. In fact, they did not affect development of eggs, hatching, and larval survival. The extract activities were dose dependent. The ethanolic extract was more potent against embryonation (39.6 ± 2.9%) than the aqueous extract (53.3 ± 10.9%) at the highest concentration (3.75 mg·ml−1). Both types of extracts killed larvae. Mebendazole proved more lethal (EC50 of 0.745 and 0.323 mg·mL−1, resp., for L1 and L2 larvae). The aqueous extracts were the least lethal (EC50 of 4.76 and 2.29 mg·mL−1, resp., for L1 and L2 larvae). The ethanolic extracts showed intermediate activity (EC50 of 1.323 and 1.511 mg·mL−1, resp., for L1 and L2 larvae). It is concluded that the ovicidal and larvicidal properties of aqueous and ethanolic extracts of Ageratum conyzoides leaves are demonstrated in this work.